The New York Eye Cancer Center
New York, New York, United States
Cancer treatment center in New York City, New York
115 E 61st St # 5B, New York, NY 10065
About The New York Eye Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at The New York Eye Cancer Center
During the past decade, The New York Eye Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "The New York Eye Cancer Center"
#1 collaborator was "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at The New York Eye Cancer Center
According to Clinical.Site data, the most researched conditions in "The New York Eye Cancer Center" are
"Radiation Retinopathy" (2 trials), "Choroidal Melanoma" (1 trials) and "Conjunctival Neoplasms" (1 trials). Many other conditions were trialed in "The New York Eye Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at The New York Eye Cancer Center
Most popular intervention types in "The New York Eye Cancer Center" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "ranibizumab" (2 trials), "Ranibizumab" (1 trials) and "ranibizumab 2.0 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The New York Eye Cancer Center
The vast majority of trials in "The New York Eye Cancer Center" are
3 trials for "All" genders.
Clinical Trials Status at The New York Eye Cancer Center
Currently, there are NaN active trials in "The New York Eye Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in The New York Eye Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The New York Eye Cancer Center, 3 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".